“Real-World Switch Rates for Patients With Psoriasis Initiating Risankizumab Stratified by Body Mass Index”. 2023. SKIN The Journal of Cutaneous Medicine 7 (6): s248. https://doi.org/10.25251/skin.7.supp.248.